X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
At a glance
Keep dosing times, dose steps and problem medicines in view — free in the brite app.
For a muscle to contract, the nerve releases the messenger substance acetylcholine at its junction with the muscle (the motor end plate). Acetylcholine docks onto receiving sites (receptors) on the muscle. In myasthenia gravis (literally “serious muscle weakness”), the immune system produces antibodies against precisely these receptors or against neighbouring proteins. The signal then arrives only in weakened form — especially when a muscle has to work repeatedly.¹,²
This gives the disease its hallmark: the muscles are not permanently paralysed but tire unusually quickly. After a rest, they recover. In the morning many things still go well; by evening the eyelid droops, the voice grows quieter and chewing becomes an effort.²
Myasthenia gravis is rare, but among rare diseases it is one of the more common ones. There are two age peaks: younger adults, especially women, and older people from around 60, in whom the disease has been recognised much more often in recent decades. One important point up front: myasthenia is very treatable today. With the right treatment, most people affected lead a largely normal life.¹
The guideline classifies myasthenia by the extent of the symptoms, by age at onset and by the antibodies that can be detected. This classification is not just theory — it helps decide which treatment is an option.¹
By antibody, the main distinctions are:
| Antibody | Classification | What it means for treatment |
|---|---|---|
| Against the acetylcholine receptor (AChR) | The large majority of generalised forms; detectable less often in the purely ocular form | Thymectomy can be worthwhile; most of the new antibody treatments are approved for this group |
| Against MuSK (muscle-specific kinase) | Small group, often with marked weakness in swallowing, speaking and the neck | Pyridostigmine often works less well; rituximab is frequently effective; thymectomy not recommended |
| Against LRP4 | Rare, tends to take a milder course | Treated much as with AChR antibodies |
| No detectable antibody (seronegative) | Diagnosis based on nerve tests and the course | Individual decision |
The key symptom is fluctuating weakness that depends on exertion, without pain and without any loss of sensation. It is usually worse in the evening, in the heat, during infections and under stress.²
Why the immune system turns against the junction between nerve and muscle has not been fully explained. According to current knowledge, several factors work together:¹,²
The neurologist makes the diagnosis from the typical clinical picture plus at least one confirming finding: antibodies, electrical nerve tests or a response to a test medicine.¹
Because the symptoms fluctuate, it helps to note the time and type of weakness over a few days or to photograph it with your phone — for example your eyelid in the morning and in the evening. This captures a picture that may not be visible at that very moment in the consultation.
Treatment rests on two pillars: medicines that improve signal transmission symptomatically, and immunotherapy that slows down antibody production. According to the guideline, the goal is a state with at most minimal symptoms and as few side effects as possible. Which step you need depends on severity, antibody type, age, thymus findings and your other conditions — the decision is made by the treating practice, ideally in consultation with a myasthenia centre.¹
Put honestly: the new antibody treatments often work quickly and noticeably, but they are very expensive, not approved for all antibody types and are therefore used selectively in disease that is not adequately controlled with basic treatment. Long-term data covering many years are, by their nature, still lacking.¹
If there is a thymoma, the thymus gland is usually removed. Without a thymoma, a large randomised trial showed that thymectomy in generalised myasthenia with AChR antibodies in younger and middle-aged adults reduces symptoms and spares cortisone.¹,³ The effect only sets in after months to years; the operation is planned, not an emergency — and today it is often minimally invasive. It is not recommended with MuSK antibodies.
Pyridostigmine usually starts working within an hour and lasts a few hours. That is why it is taken several times a day, often timed so that its effect is strongest at mealtimes or during demanding activities. For the night there are prolonged-release tablets. The total amount is set by the practice; topping up on your own is not a good idea.⁴
Taken over a long period, cortisone can increase weight, blood sugar and blood pressure, disturb sleep, weaken the bones and increase susceptibility to infection. Bone protection and checks of blood sugar and blood pressure are therefore part of treatment; details in the cortisone guide.¹
Inactivated vaccines, for example against flu, pneumococci, COVID-19 or shingles, are recommended for people with myasthenia; live vaccines are generally off limits under immunosuppression. Ideally, your vaccination status is checked before starting immunotherapy, see Vaccines and medications.¹
brite reminds you of every dose and checks new prescriptions against your myasthenia medicines.
This is where people with myasthenia can contribute most themselves. Many common medicines weaken transmission between nerve and muscle even further. Not all of them are forbidden — often it is a matter of weighing up, dose and monitoring. But every new prescription should be checked with your myasthenia in mind.¹,⁵
| Drug group | Examples | Classification |
|---|---|---|
| Antibiotics: aminoglycosides | Gentamicin, tobramycin | Avoid if possible; if indispensable, only under monitoring |
| Antibiotics: fluoroquinolones | Ciprofloxacin, levofloxacin, moxifloxacin | Only with caution according to the summary of product characteristics; can markedly increase weakness |
| Antibiotics: macrolides | Clarithromycin, azithromycin, erythromycin | Worsening has been described; check alternatives |
| Magnesium | Especially as an infusion, also high-dose products | Inhibits the release of acetylcholine; only take magnesium after discussing it |
| Beta blockers | Metoprolol, propranolol, also as eye drops (timolol) | Can make it worse; can be used with caution when clearly indicated |
| Antimalarials and quinine | Hydroxychloroquine, chloroquine, quinine (also in larger amounts of tonic water and bitter drinks) | Can trigger or worsen myasthenia |
| Botulinum toxin | Cosmetic or medical | Contraindicated in myasthenia according to the summary of product characteristics |
| Cancer immunotherapy | Checkpoint inhibitors | Can trigger severe myasthenia; close coordination with the oncology team |
| Anaesthetics and muscle relaxants | During operations | Inform the anaesthetist about the myasthenia beforehand |
This list is not complete. Some statins, benzodiazepines and medicines for heart rhythm disorders have also been linked to worsening. The Deutsche Myasthenie Gesellschaft (German Myasthenia Society) provides a detailed list and an emergency card.⁵ In practice, this means: combine every new prescription — including at the dentist, in the emergency department or at the pharmacy — with the words “I have myasthenia”. A check with the interaction check and the guide Taking antibiotics correctly helps with that conversation.
In a crisis, the breathing or swallowing muscles fail to such an extent that ventilation or tube feeding may become necessary. Common triggers are infections, unsuitable medicines, operations and stopping immunotherapy. In hospital, treatment consists of immunoglobulins as an infusion or blood purification (plasmapheresis, immunoadsorption), which rapidly reduce the antibodies. With modern intensive care, the outlook today is usually good.¹,²
Planned procedures should ideally be carried out during a stable phase. The anaesthetist and surgeon need the diagnosis and the complete medication list; the team decides whether pyridostigmine is taken on the day of surgery. More on this in the guide Medications before surgery.
Pregnancy is generally possible with myasthenia but should be planned. The course during pregnancy varies; the myasthenia can get worse particularly in the weeks after the birth. Mycophenolate and methotrexate must be stopped beforehand, pyridostigmine and cortisone are considered acceptable, and azathioprine is often continued after weighing up the pros and cons. Magnesium infusions, as commonly used for pre-eclampsia, are problematic. Some newborns develop temporary muscle weakness (neonatal myasthenia) because maternal antibodies are passed on — the birth should therefore take place in a hospital with a paediatric unit.¹ The basics are covered in the guide Medications during pregnancy.
Myasthenia demands attention, but it is not a disease you are at the mercy of. Most flare-ups have a trigger — an infection, a new medicine, a forgotten or discontinued tablet. That is exactly where the levers lie in everyday life.
Record weakness, dosing times and infections over time — for your next neurology appointment.
Dose reminders, interaction check and progress tracking in one place. Free.
Start for free